Source Paper
Source Paper
Hiroyuki Nakayama, Xiongwen Chen, Christopher P. Baines, Raisa Klevitsky, Xiaoying Zhang et al.
Journal of Clinical Investigation • 2007
Loss of cardiac myocytes in heart failure is thought to occur largely through an apoptotic process. Here we show that heart failure can also be precipitated through myocyte necrosis associated with Ca2+ overload. Inducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel (LTCC) activity showed progressive myocyte necrosis that led to pump dysfunction and premature death, effects that were dramatically enhanced by acute stimulation of beta-adrenergic receptors. Enhanced Ca2+ influx-induced cellular necrosis and cardiomyopathy was prevented with either LTCC blockers or beta-adrenergic receptor antagonists, demonstrating a proximal relationship among beta-adrenergic receptor function, Ca2+ handling, and heart failure progression through necrotic cell loss. Mechanistically, loss of cyclophilin D, a regulator of the mitochondrial permeability transition pore that underpins necrosis, blocked Ca2+ influx-induced necrosis of myocytes, heart failure, and isoproterenol-induced premature death. In contrast, overexpression of the antiapoptotic factor Bcl-2 was ineffective in mitigating heart failure and death associated with excess Ca2+ influx and acute beta-adrenergic receptor stimulation. This paradigm of mitochondrial- and necrosis-dependent heart failure was also observed in other mouse models of disease, which supports the concept that heart failure is a pleiotropic disorder that involves not only apoptosis, but also necrotic loss of myocytes in association with dysregulated Ca2+ handling and beta-adrenergic receptor signaling.
Objective: Assessment of isoproterenol-induced premature death and heart failure in transgenic mouse models with enhanced L-type Ca2+ channel activity, examining the role of mitochondrial-dependent cardiomyocyte necrosis
This is a Isoproterenol-induced Cardiomyopathy Model protocol using mouse as the model organism. The procedure involves 8 procedural steps. Extracted from a 2007 paper published in Journal of Clinical Investigation.
Model and subjects
mouse • transgenic mice with enhanced sarcolemmal L-type Ca2+ channel (LTCC) activity • unknown • not specified • not specified
Study window
Estimated timing pending
Core workflow
Transgenic mouse model generation and characterization • Acute β-adrenergic receptor stimulation • Isoproterenol treatment
Primary readouts
Key equipment and reagents
Verified items
0
Direct vendor links
0
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
Use the page like this
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Inducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel (LTCC) activity were used as the primary model system
Note: These mice showed progressive myocyte necrosis leading to pump dysfunction and premature death
“Inducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel (LTCC) activity showed progressive myocyte necrosis that led to pump dysfunction and premature death”
Acute stimulation of β-adrenergic receptors was applied to transgenic mice, which dramatically enhanced myocyte necrosis and cardiomyopathy effects
Note: This stimulation enhanced the effects of enhanced Ca2+ influx
“effects that were dramatically enhanced by acute stimulation of β-adrenergic receptors”
Isoproterenol was administered to induce premature death in transgenic mouse models
Note: Loss of cyclophilin D blocked isoproterenol-induced premature death
“loss of cyclophilin D, a regulator of the mitochondrial permeability transition pore that underpins necrosis, blocked Ca2+ influx–induced necrosis of myocytes, heart failure, and isoproterenol-induced premature death”
L-type Ca2+ channel blockers were administered to test whether they could prevent enhanced Ca2+ influx-induced cellular necrosis and cardiomyopathy
Note: LTCC blockers successfully prevented necrosis and heart failure
“Enhanced Ca2+ influx–induced cellular necrosis and cardiomyopathy was prevented with either LTCC blockers or β-adrenergic receptor antagonists”
β-adrenergic receptor antagonists were administered to test whether they could prevent enhanced Ca2+ influx-induced cellular necrosis and cardiomyopathy
Note: β-adrenergic receptor antagonists successfully prevented necrosis and heart failure
“Enhanced Ca2+ influx–induced cellular necrosis and cardiomyopathy was prevented with either LTCC blockers or β-adrenergic receptor antagonists”
Transgenic mice with loss of cyclophilin D were evaluated to determine the role of mitochondrial permeability transition pore regulation in heart failure and premature death
Note: Loss of cyclophilin D blocked Ca2+ influx-induced necrosis, heart failure, and isoproterenol-induced premature death
“loss of cyclophilin D, a regulator of the mitochondrial permeability transition pore that underpins necrosis, blocked Ca2+ influx–induced necrosis of myocytes, heart failure, and isoproterenol-induced premature death”
Transgenic mice with Bcl-2 overexpression were evaluated to determine whether antiapoptotic factors could mitigate heart failure and death associated with excess Ca2+ influx
Note: Bcl-2 overexpression was ineffective in preventing heart failure and death
“overexpression of the antiapoptotic factor Bcl-2 was ineffective in mitigating heart failure and death associated with excess Ca2+ influx and acute β-adrenergic receptor stimulation”
The paradigm of mitochondrial- and necrosis-dependent heart failure was tested in other mouse models of disease beyond the primary LTCC transgenic model
Note: Results supported the concept that heart failure involves both apoptosis and necrotic loss of myocytes
“This paradigm of mitochondrial- and necrosis-dependent heart failure was also observed in other mouse models of disease”
This section explains what the experiment is doing, which readouts matter, what the data artifacts usually look like, and how the analysis should flow from raw capture to reported result.
Assessment of isoproterenol-induced premature death and heart failure in transgenic mouse models with enhanced L-type Ca2+ channel activity, examining the role of mitochondrial-dependent cardiomyocyte necrosis
Objective
Assessment of isoproterenol-induced premature death and heart failure in transgenic mouse models with enhanced L-type Ca2+ channel activity, examining the role of mitochondrial-dependent cardiomyocyte necrosis
Subjects
From papermouse • transgenic mice with enhanced sarcolemmal L-type Ca2+ channel (LTCC) activity • unknown • not specified • not specified
Cohort notes
From paperInducible transgenic mice; also included other mouse models of disease; some mice had loss of cyclophilin D; some had Bcl-2 overexpression
Transgenic mouse model generation and characterization (not specified)
Acute β-adrenergic receptor stimulation (not specified)
Isoproterenol treatment (not specified)
Pharmacological intervention with L-type Ca2+ channel blockers (not specified)
Premature death occurrence and timing
From papernot specified in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Heart failure development and progression
From papernot specified in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Myocyte necrosis extent and progression
From papernot specified in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Pump dysfunction severity
From papernot specified in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Premature death occurrence and timing
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Heart failure development and progression
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Myocyte necrosis extent and progression
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Pump dysfunction severity
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Acquisition
Collect raw experimental outputs with enough metadata to preserve sample identity, condition, and timing.
Preprocessing / cleaning
not specified in provided text
Scoring or quantification
Quantify the primary readouts for this experiment: Premature death occurrence and timing; Heart failure development and progression; Myocyte necrosis extent and progression; Pump dysfunction severity.
Statistical comparison
Statistical method not yet structured for this page.
Reporting output
Report representative outputs alongside summary comparisons for Premature death occurrence and timing, Heart failure development and progression, Myocyte necrosis extent and progression, Pump dysfunction severity.
Source links and direct wording from the methods section for validation and deeper review.
Citation
Hiroyuki Nakayama et al. (2007). Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. Journal of Clinical Investigation
“”
“”
“”
“”
Direct vendor pages are linked from the protocol above. This section stays focused on the full comparison view and the prep checklist.
Use this section as the page quality checkpoint. It keeps section navigation, evidence access, readiness, and verification meaning in one place.
Current status surfaces were computed from experiment data updated Feb 28, 2026.
Source access
Jump back into the original paper or the methods evidence section when you need exact wording, exclusions, or method-specific caveats.
This protocol has structured steps plus evidence quotes, and is ready for canonical sync.
Steps
8
Evidence Quotes
8
Protocol Items
0
Linked Products
0
Canonical Sync
Pending
What this means
The completeness score reflects how much structured protocol data is present: steps, methods evidence, listed materials, linked products, and paper provenance.
Computed from the current experiment record updated Feb 28, 2026.
Canonical Sync shows whether a ConductGraph-backed protocol is available for this experiment route right now. It is a sync-status signal, not a claim that every downstream vendor link or step detail is perfect.
Steps
8
Evidence
8
Specific Products
0/0
Canonical Sync
Pending
What this score means
The verification score reflects evidence coverage, subject detail, paper provenance, step depth, and whether linked products resolve to specific item pages instead of generic searches.
Computed from the current experiment record updated Feb 28, 2026.
A page can have structured steps and still need review when evidence is thin, product links are generic, or canonical protocol coverage is still pending.
What still needs work